Stefan Kukacka is new CEO at schülke

Norderstedt, Juli 1, 2022. Stefan Kukacka will take over as CEO at schülke, effective July 1, 2022. As Chief Executive Officer (CEO) of the international market leader in infection prevention and hygiene solutions, he succeeds Heinz Jacqui. Jacqui has led the company as Interim CEO since December 1, 2021.

Stefan Kukacka has more than 25 years of professional and leadership experience with internationally operating companies. Most recently, Stefan Kukacka was responsible for Austria and Eastern Europe as Managing Director at Beiersdorf. In addition to his experience in industry, Kukacka spent more than six years as a management consultant with the management consultancy A.T. Kearney in the USA. Stefan Kukacka started his career after studying at the Vienna University of Economics and Business Administration and the Rotterdam School of Management. He is a native Austrian, married and has two children.

"As CEO for schülke, Stefan Kukacka will bring his extensive expertise in sales and marketing as well as in the hospital environment and over-the-counter sector," said Stefan F. Heidenreich, Chairman of the Board of Directors. "We wish him every success for his diverse and challenging tasks."

"I am very much looking forward to the task and to contributing my personal share to schülke's mission 'we protect lives worldwide'," emphasizes Stefan Kukacka. In order to increasingly drive the mission forward, schülke is positioning itself to be even more focused, agile and powerful.

"We want to further strengthen our market leadership in our core markets, expand into new markets and be the preferred partner of choice for our customers," says Stefan Kukacka on his arrival.

"In addition, it is of great importance for us to successfully develop the innovation pipeline. With a new focused structure, we will accelerate decision-making processes and align ourselves even more clearly with our customers."

Therefore, schülke's Management Committee is now composed as follows:

• Stefan Kukacka, Chief Executive Officer (CEO) - Managing Director (Chairman)
• Hans-Christian Nehlsen, Chief Finance Officer (CFO) - Managing Director
• Lars Lemke, Chief Operating Officer (COO)
• Dr. Sven Pfleging, Chief Commercial Officer (CCO)

"We would like to thank Heinz Jacqui for his successful management and further development of schülke," Heidenreich continued. "In his role as interim CEO, schülke has benefited greatly from his extensive experience in the healthcare industry."

"Furthermore, on behalf of the Board of Directors and shareholder EQT, I would like to thank all employees for their continued commitment to schülke and wish all members of the Management Committee and their teams every success in implementing our ambitious growth strategies and further developing schülke into the leading provider of infection prevention for the healthcare industry and a "Best in Class" company in the market," Heidenreich added.

Schülke & Mayr

Schülke & Mayr GmbH has been an international leader in infection prevention and control for more than 130 years. With its wide range of high-quality and innovative products, expert advice and reliable service, schülke offers holistic concepts for infection prevention in professional healthcare, for end consumers and the pharmaceutical sector. Committed to our mission of protecting lives worldwide, we actively contribute to the safety and protection of human health in our strategic business areas of Healthcare, Over the Counter (OTC) and Industrial Hygiene. Because infectious agents know no borders. This has always been true and is even more important in today's globalized world.

schülke has more than 1,000 dedicated employees, over 15 subsidiaries and three production sites in Germany (schülke), France (Bioxal) and Brazil (Vic Pharma), and people in more than 80 countries around the world rely on our products every day. www.schuelke.de